Zoetis | ZTS - Operating Expenses


Zoetis reported $3.23B in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
AbbVie USD 10.27B 538M Mar/2026
Align Technology USD 862.03M 39.18M Mar/2026
Bayer EUR 9.88B 452M Mar/2026
Bristol-Myers Squibb USD 20.07B 11.77B Mar/2026
Charles River Laboratories USD 875.93M 42.48M Mar/2026
Coherus Biosciences USD 51.83M 2.48M Dec/2025
Dentsply International USD 1.32B 895M Mar/2026
Eli Lilly USD 10.02B 285M Mar/2026
Henry Schein USD 3.17B 77M Mar/2026
Idexx Laboratories USD 778.23M 3.26M Mar/2026
Illumina USD 852M 51M Mar/2026
IQVIA Holdings USD 6.22B 4.53B Mar/2026
J&J USD 17.83B 388M Jun/2026
Laboratory Of America USD 3.13B 6.3M Mar/2026
Merck USD 18.17B 8.01B Mar/2026
Neogen USD 214.5M 15.57M Dec/2025
Pacira USD 172.75M 20.93M Mar/2026
Perrigo USD 935.6M 89.6M Mar/2026
Pfizer USD 90.1B 77.19B Mar/2026
Phibro Animal Health USD 361.83M 29.47M Mar/2026
Quest Diagnostics USD 2.5B 76M Mar/2026
Sanofi EUR 9.31B 1.2B Mar/2026
Sanofi EUR 8.98B 1.73B Mar/2026
Zoetis USD 3.23B 1.68B Mar/2026